治疗性屈光玻璃体切除术用于管理玻璃体飞蚊症和混浊:基于飞蚊症和混浊标准化及动态解剖与功能测试的评估
回顾性分析20只眼接受治疗性屈光玻璃体切除术(TRV)以选择性清除症状性玻璃体飞蚊症和混浊。术后杂散光测量下降(HD Analyzer 22%、光干扰分析仪54.4%、C-Quant 7.8%),患者报告结局显著改善(P=0.022),而矫正远视力变化轻微。新型超广角OCT成像证实玻璃体清晰度恢复。
要点
- TRV术后光干扰分析仪杂散光下降54.4%(P=0.013),C-Quant下降7.8%(P=0.034)。
- 患者报告结局显著改善(P=0.022),但矫正远视力变化轻微。
- 新型超广角OCT(26 mm×12 mm)确认玻璃体后脱离状态(100%)并显示玻璃体清晰度恢复。
核心结论
- 治疗性屈光玻璃体切除术是治疗性屈光手术的重要贡献,是提高视觉质量、矫正屈光性和混浊性玻璃体异常的安全有效方法。
- 矫正远视力改善极小,作为全面视觉功能衡量指标的有效性有限。
- 客观杂散光测量和成像的改善与术后主观症状改善一致,强调超越传统指标的新整体评估方法的价值。
研究设计与样本
- 回顾性分析,20只眼接受治疗性屈光玻璃体切除术以治疗症状性玻璃体飞蚊症和混浊。
- 术前和术后评估包括飞蚊症和混浊标准化及动态解剖与功能测试,含杂散光测量(HD Analyzer、光干扰分析仪、C-Quant)及非接触成像(包括新型超广角光学相干断层扫描)。
主要发现
- 术后杂散光测量下降:HD Analyzer 22%、光干扰分析仪54.4%(P=0.013)、C-Quant 7.8%(P=0.034)。
- 患者报告结局统计学显著改善(P=0.022)。
- 矫正远视力变化轻微。
- 新型超广角26 mm×12 mm成像窗口OCT确认玻璃体后脱离状态(100%),术后成像显示玻璃体清晰度恢复、残留皮质玻璃体存在且无新发玻璃体后脱离。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Propose new terminology and evaluate the effectiveness of therapeutic refractive vitrectomy (TRV) for selective removal of vitreous floaters and opacities using Standardized Kinetic Anatomical Functional Testing of Vitreous Floaters and Opacities and new ultra widefield optical coherence tomography imaging techniques. METHODS: Retrospective analysis. Twenty eyes underwent therapeutic refractive vitrectomy for symptomatic vitreous floaters and opacities. Pre-TRV assessments/post-TRV assessments: Standardized and Kinetic Anatomical and Functional Testing of Vitreous Floaters and Opacities, including straylight measurements (HD Analyzer, Light Disturbance Analyzer, C-Quant) alongside noncontact imaging including a new ultra widefield optical coherence tomography to evaluate changes in vitreous anatomical and optical properties. RESULTS: Post-TRV evaluations indicated objective changes in vitreous optical properties and subjective measures. Reduced straylight measurements: HD Analyzer 22%, light disturbance analyzer 54.4% ( P = 0.013), and C-Quant 7.8% ( P = 0.034). Patient-reported outcomes statistically significantly improved ( P = 0.022). Corrected distance visual acuity changes were marginal. New ultra widefield 26 mm by 12 mm imaging window optical coherence tomography facilitated detailed vitreous imaging, confirming the status of posterior vitreous detachment (100%). Post-TRV ultra widefield and optical coherence tomography imaging demonstrated restoration of vitreous clarity, confirmed the presence of residual cortical vitreous and absence of new posterior vitreous detachments. CONCLUSION: Therapeutic refractive vitrectomy is a significant contribution for therapeutic refractive surgery as a safe and effective approach to enhancing visual quality, correcting refractive and opaque vitreous anomalies. Improvement in corrected distance visual acuity was minimal, representing limited effectiveness as a measure of comprehensive visual function. Improvements in objective straylight measures and imaging are in alignment with subjective symptom improvements post-TRV. This underscores the utility and value of new holistic evaluation methods beyond traditional metrics to assess the impact of therapeutic refractive vitrectomy on visual function and quality of life.
引用
- Stanga PE, Reinstein DZ, Valentin Bravo FJ, et al. THERAPEUTIC REFRACTIVE VITRECTOMY FOR THE MANAGEMENT OF VITREOUS FLOATERS AND OPACITIES ASSESSED BY THE STANDARDIZED AND KINETIC ANATOMICAL AND FUNCTIONAL TESTING OF VITREOUS FLOATERS AND OPACITIES. Retina. 2025. PMID: 39693577. doi:10.1097/IAE.0000000000004373
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。